Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment-Naive Adults With Chronic Hepatitis C Virus (HCV) Genotype 1-6 Infection and Compensated Cirrhosis

ClinicalTrials.gov ID: NCT03089944

Public ClinicalTrials.gov record NCT03089944. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 11:21 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Single Arm, Open-label Study to Evaluate the Efficacy and Safety of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment Naïve Adults With Chronic Hepatitis C Virus (HCV) Genotype 1-6 Infection and Compensated Cirrhosis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A Phase 3b, single arm, open-label, multicenter study in treatment naïve adults with chronic HCV infection and compensated cirrhosis to assess the safety of 8 weeks of treatment with glecaprevir/pibrentasvir and to demonstrate the efficacy of the sustained virologic response 12 weeks post dosing (SVR12) rates of 8 weeks of treatment with glecaprevir/pibrentasvir compared to the historical SVR12 rates of 12 weeks of treatment with glecaprevir/pibrentasvir.

Study identification

NCT ID
NCT03089944
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AbbVie
Industry
Enrollment
343 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 28, 2017 (Actual)
Primary completion
Jul 31, 2019 (Actual)
Completion
Nov 8, 2019 (Actual)
Last update posted
Jul 13, 2020

2017 – 2019

United States locations

U.S. sites
40
U.S. states
23
U.S. cities
35
Facility City State ZIP Site status
St. Josephs Hosp and Med Ctr /ID# 162762 Phoenix Arizona 85013 —
Mayo Clinic Arizona /ID# 162314 Phoenix Arizona 85054 —
Liver Wellness Center /ID# 162244 Little Rock Arkansas 72204 —
Felizarta /ID# 162295 Bakersfield California 93301 —
VA Long Beach Healthcare System /ID# 162298 Long Beach California 90822 —
Usc /Id# 162248 Los Angeles California 90033 —
Kaiser Permanente - San Diego (Palm Ave) /ID# 162289 San Diego California 92154 —
Stanford University School of Med /ID# 162209 Stanford California 94305-2200 —
Cedars-Sinai Medical Center - West Hollywood /ID# 162313 West Hollywood California 90048 —
University of Miami /ID# 162210 Miami Florida 33136 —
Triple O Research Institute /ID# 162300 West Palm Beach Florida 33407-3100 —
Piedmont Hospital /ID# 162646 Atlanta Georgia 30309 —
Northwestern University Feinberg School of Medicine /ID# 162208 Chicago Illinois 60611-2927 —
Unity Point Health /ID# 162247 Des Moines Iowa 50309 —
The University of Iowa Hospita /ID# 162214 Iowa City Iowa 52242 —
University of Louisville /ID# 162242 Louisville Kentucky 40202 —
Louisiana Research Ctr. LLC /ID# 162567 Shreveport Louisiana 71105-6800 —
Mercy Medical Center /ID# 162291 Baltimore Maryland 21202 —
Mayo Clinic - Rochester /ID# 162251 Rochester Minnesota 55905-0001 —
Southern Therapy and Advanced Research (STAR) LLC /ID# 162241 Jackson Mississippi 39216 —
CHI Health Alegent Creighton /ID# 162286 Omaha Nebraska 68124 —
Univ Nebraska Med Ctr /ID# 162285 Omaha Nebraska 68198 —
Rnjms /Id# 162213 Newark New Jersey 07103 —
Weill Cornell Medical College /ID# 161051 New York New York 10021 —
Icahn School of Med Mt. Sinai /ID# 162294 New York New York 10029 —
Montefiore Medical Center /ID# 162312 The Bronx New York 10461 —
James J. Peters VA Medical Center /ID# 162644 The Bronx New York 10468 —
Duke University Medical Center /ID# 162299 Durham North Carolina 27710-3000 —
Cumberland Research Assoc /ID# 162212 Fayetteville North Carolina 28304 —
Carolinas Center for Liver Dis /ID# 162569 Statesville North Carolina 28677-3471 —
University Hospitals Cleveland /ID# 162243 Cleveland Ohio 44106 —
Cleveland Clinic /ID# 162570 Cleveland Ohio 44111 —
Osuchs /Id# 162284 Tulsa Oklahoma 74127 —
Lehigh Valley Health Network /ID# 162603 Allentown Pennsylvania 18103 —
Center for Liver Diseases, Oakland /ID# 162568 Pittsburgh Pennsylvania 15213 —
Vanderbilt Univ Med Ctr /ID# 162211 Nashville Tennessee 37232-0011 —
Texas Digestive Disease Consul /ID# 162648 Dallas Texas 75246-1613 —
University of Texas Health /ID# 162288 Houston Texas 77030-1501 —
Virginia Commonwealth Univ /ID# 162215 Richmond Virginia 23219 —
Univ of Wisconsin Hosp/Clinics /ID# 162645 Madison Wisconsin 53792-0001 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 73 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03089944, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 13, 2020 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03089944 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →